Aisling Capital Management LP

Компания	Доля, %
Elevation Oncology, Inc.	5.19
Marker Therapeutics, Inc.	3.57
BridgeBio Pharma, Inc.	3.45
Spruce Biosciences, Inc.	2.93
Monte Rosa Therapeutics, Inc.	2.91
Eidos Therapeutics, Inc.	2.89
Reneo Pharmaceuticals, Inc.	2.65
AVROBIO, Inc.	2.25
Biomea Fusion, Inc.	2.22
COMPASS Pathways plc	1.56
Atreca, Inc.	1.18
Poseida Therapeutics, Inc.	1.08
Viracta Therapeutics, Inc.	0.73